Lakhmir S. Chawla, Chief Medical Officer at LA JOLLA PHARMACEUTICAL CO (LJPC), bought 485 shares at $27.75 ($13K) on 2015-09-28, disclosed to the SEC on 2015-09-30.
Open-market purchase of $13k LJPC by Chief Medical Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |